Conversely, inhibition of the activity of demethylase KDM6A/KMD6B by GSK-J4 sensitized CRC to the effect of chemotherapeutic drugs by upregulating H3K27me3 levels in vivo and in vitro. This evidence concerns the gene MBD2 and colorectal carcinoma.